Caris Life Sciences, Inc. CAI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 767.38M | 793.12M | 823.46M | 798.57M | 755.49M |
| Total Receivables | 133.32M | 116.89M | 90.52M | 112.14M | 26.70M |
| Inventory | 138.37M | 123.79M | 76.29M | 63.63M | 49.30M |
| Prepaid Expenses | 23.28M | 18.93M | 19.62M | 19.59M | 18.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.91M | 5.11M | 4.29M | 3.88M | 4.10M |
| Total Current Assets | 1.07B | 1.06B | 1.01B | 997.80M | 854.25M |
|
|
|||||
| Total Current Assets | 1.07B | 1.06B | 1.01B | 997.80M | 854.25M |
| Net Property, Plant & Equipment | 102.30M | 95.72M | 82.67M | 103.02M | 64.00M |
| Long-term Investments | 19.34M | 19.34M | 19.34M | 19.34M | 19.34M |
| Goodwill | 19.34M | 19.34M | 19.34M | 19.34M | 19.34M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 66.72M | 56.73M | 46.20M | 5.50M | 46.99M |
| Total Assets | 1.26B | 1.23B | 1.16B | 1.13B | 984.57M |
|
|
|||||
| Total Accounts Payable | 63.84M | 85.99M | 69.80M | 39.21M | 29.00M |
| Total Accrued Expenses | 70.36M | 78.39M | 43.12M | 56.92M | 47.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.38M | 6.55M | 6.01M | 6.53M | 6.61M |
| Total Finance Division Other Current Liabilities | 18.37M | 20.52M | 24.97M | 24.49M | 2.79M |
| Total Other Current Liabilities | 18.37M | 20.52M | 24.97M | 24.49M | 2.79M |
| Total Current Liabilities | 158.95M | 191.44M | 143.90M | 127.15M | 86.03M |
|
|
|||||
| Total Current Liabilities | 158.95M | 191.44M | 143.90M | 127.15M | 86.03M |
| Long-Term Debt | 393.18M | 392.97M | 381.40M | 378.45M | 376.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 63.47M | 52.88M | 43.55M | 42.71M | 43.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 552.00K | 592.00K | 53.00K | 53.00K | 53.00K |
| Total Liabilities | 616.14M | 637.89M | 568.90M | 548.36M | 506.21M |
|
|
|||||
| Common Stock & APIC | 3.17B | 3.14B | 3.16B | 3.14B | 3.13B |
| Retained Earnings | -2.53B | -2.55B | -2.55B | -2.55B | -2.63B |
| Treasury Stock & Other | -105.00K | 529.00K | -16.00M | -15.96M | -16.17M |
| Total Common Equity | 639.48M | 591.73M | 593.49M | 577.31M | 478.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 639.48M | 591.73M | 593.49M | 577.31M | 478.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 639.48M | 591.73M | 593.49M | 577.31M | 478.36M |
|
|
|||||